Clinical Trials Browser

NCT05983536 2023-08-09

The Evaluation of Anti-interference Ability and Clinical Specificity of HIV Ag +Ab Assay Kit (Sysmex)

Unknown

1,200 enrolled

Hematologic Diseases, HIV Seropositivity, Neoplasms

NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Phase 1 Unknown

29 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT05080907 2022-11-09

Collection and Distribution of Biospecimens for Novel Research

Unknown

100,000 enrolled

Autoimmune Diseases, Communicable Diseases, Hematologic Diseases, Neoplasms, Skin Diseases

NCT05147493 2022-03-29

A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Phase 2 Unknown

51 enrolled

Plasma cell

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT05298683 2022-03-28

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Phase 2 Unknown

108 enrolled

Plasma cell

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT04720144 2021-02-09

BIMI

Unknown

300 enrolled

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

NCT02380378 2019-04-02

MPN

Unknown

500 enrolled

Hematologic Diseases

NCT03868527 2019-03-11

Arcan database

Unknown

13,000 enrolled

Hematologic Diseases

NCT03272789 2019-01-23

REBOND

Phase NA Unknown

32 enrolled

Hematologic Diseases, Neoplasms

NCT03556748 2018-06-14

WB-EMS and Nutrition in Patients With Hematological Malignancies

Phase NA Unknown

40 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Cachexia, Hematologic Diseases, Leukemia, Lymphoma, Motor Activity, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT02806791 2016-06-21

Efficacy of Biosimilar Filgrastim on the Mobilization of Hematopoietic Stem Cell CD34+ (Cluster of Differentiation 34) and on the Kinetic Engraftment

Unknown

300 enrolled

Hematologic Diseases

NCT02456818 2016-02-08

CONTAIN

Unknown

2,264 enrolled

Hematologic Diseases

NCT01435720 2014-09-11

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

Phase 1/2 Unknown

15 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Blood Protein Disorders, Hematologic Diseases, Leukemia, Plasma Cell, Multiple Myeloma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell

NCT00866762 2011-12-12

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Phase 2 Unknown

60 enrolled

Myeloid

Hematologic Diseases, Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

NCT00883961 2009-12-23

Exercise Following Autologous Peripheral Blood Stem Cell Transplantation

Phase 3 Unknown

60 enrolled

Fatigue, Hematologic Diseases, Motor Activity, Neoplasms